For DNMT3A, although IHC data exhibited intrapatient heterogeneity in some tumors with different intensities in different tumor areas (Fig. 5H), a general trend of high CD8 + TILs associated with weak staining of DNMT3A was observed and vice versa. The gene discussed is CD8A; the disease is neoplasm.